
Dad and husband | Pancreas Surgeon @MCWSurgery @MCWPancProgram Fellowship @MDAndersonNews Views are my own
Milwaukee, WI
Joined July 2022
- Tweets141
- Following140
- Followers218
- Likes451
Y. David Seo MD retweeted
Congratulations to Dr. Nikki Lytle! Dr. Lytle has recently been awarded a $2.25M R01 grant from the National Cancer Institute (@theNCI) for the project titled, “Regulation of cell state plasticity in breast tumorigenesis.”👏 @mcwsurgonc #LeadingTheWay
Y. David Seo MD retweeted
Amazing news today, culmination of years of research & clinical trials in #PancreaticCancer.
The @RevMedicines approval for Rasonque (Daraxonrasib) will open many doors, including other inhibitors in this space & combinations. @OncoAlert @KRASKickers
fda.gov/news-events/press-an…
Y. David Seo MD retweeted
Congratulations to Dr. Beth Erickson, Professor of Radiation Oncology & Chief of Brachytherapy Services, on being ASTRO's President-elect!
We're proud to have Dr. Beth Erickson on our team!
Read more here:
bit.ly/dr-erickson-astro
#RadiationOncology #ASTRO #MCW
Y. David Seo MD retweeted
@SamThaljiMD out with a bang! What a case for your last day as fellow! We look exhausted 😂. Well done. It’s has been a privilege being apart of your journey.
Y. David Seo MD retweeted
Another @MCWSurgery resident #leadingtheway! Congratulations Dr Kshitij Gaur and his faculty mentor @DavidSeoMD!
Congratulations to Kshitij Gaur, MD, MS for being accepted to the T32 Biobehavioral Oncology Training program! 👏 #LeadingTheWay @MCWSurgery @mcwsurgonc @DavidSeoMD
Y. David Seo MD retweeted
Recently published in @FrontOncology: "Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series." @DavidSeoMD @mcwsurgonc
bit.ly/4e5LmSR
Y. David Seo MD retweeted
Data from Tango slide deck of PRMT5inh plus KRASinh (Daraxonrasib, left and Zoldonrasib, right) in 2nd/3rd line #PancreaticCancer
ir.tangotx.com/static-files/…
In this recent study (Boston Gene), ~20% of pancreatic cancers have KRAS mut plus MTAP co-deletion.
aacrjournals.org/clincancerr…
Top line data from Tango Therapeutics PRMT5 inh (Vopimetostat) plus @RevMedicines Daraxonrasib or Zoldonrasibin 2nd+ line #PancreaticCancer
ir.tangotx.com/news-releases…
Daraxonrasib (left) and Zoldonrasib (right) combination data. MultiRAS inhibition better than allele specific.
Y. David Seo MD retweeted
Replying to @anai_lab
@anai_lab @anaikothari and @SamThaljiMD have developed an EMR derived biomarker for pancreas cancer. Read more about it below! @mcwsurgonc @MCWPancProgram
#KnowledgeSavingLife
mcw.edu/mcwknowledge/mcw-sto…
Y. David Seo MD retweeted
🚨🚨🚨
RASOLUTE-302 Ph3 is POSITIVE
"Daraxonrasib demonstrated a median OS of 13.2 months versus 6.7 months for chemotherapy, with a hazard ratio of 0.40 (p < 0.0001)".... WOW!
AMAZING news for patients with #PancreaticCancer
The RAS Revolution is ON!!
ir.revmed.com/news-releases/…
Y. David Seo MD retweeted
Congratulations to Dr. Nikki Lytle! Dr. Lytle received a research grant award from @RolfeFoundation for, "Pancreatic cancer metastasis prevention through precision medicine-based immune modulation!" 👏 #LeadingTheWay @mcwsurgonc
Y. David Seo MD retweeted
Congratulations to @anaikothari, @SamThaljiMD, @anai_lab and the entire @MCWPancProgram on this outstanding work published in JAMA Surgery, leveraging AI to advance the science of pancreatic surgery. Proud of this impactful work! @MedicalCollege @MCWSurgResearch
An #AI-derived electronic tumor marker, e19-9, demonstrated utility as a noninvasive biomarker for treatment response and prognosis among patients with #PancreaticCancer who do not produce elevated CA19-9.
ja.ma/4se03Jv
Y. David Seo MD retweeted
Congratulations to Dr. Kothari on his appointment as Associate Editor for Annals of Surgery Open!
Y. David Seo MD retweeted
Congratulations to Dr. Nikki Lytle! Dr. Lytle recently received a @Lombardi_Fdn Research Grant for, "Therapeutic opportunities for preventing metastasis by harnessing Kupffer cells!" 👏 #LeadingTheWay @mcwsurgonc
Y. David Seo MD retweeted
Thank you @MedicalCollege #LaBahnPancreaticCancerProgram for inviting me! @DougEvans2273 @whallradonc @DavidSeoMD
Y. David Seo MD retweeted
Featured: Comparison between Neoadjuvant Chemoradiotherapy and Chemotherapy for Patients with Resectable #PancreaticCancer @ItaruEndo
ow.ly/MRnc50XpeGC
@jhatjhmi1
@SyedAAhmad5
@SocSurgOnc
Y. David Seo MD retweeted
Very interesting (albeit correlative) @CIR_AACR paper from @UW showcasing the power of dissecting cellular neighborhoods in spatial data:
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunity
aacrjournals.org/cancerimmun…
Y. David Seo MD retweeted
Two papers in @CR_AACR highlighting the unique biology of KRASG12R allele in #PancreaticCancer:
(A) weaker MAPK activation leading to greater MAPKi sensitivity
aacrjournals.org/cancerres/a…
(B) PTEN oxidation dependent (and KRAS independent) PI3K activation
aacrjournals.org/cancerres/a…
Y. David Seo MD retweeted
Congrats to the 10 medical student researchers selected as winners of the Dr. Michael J. Dunn Summer Research Poster Contest!
Dr. Nikki Lytle mentored Troy Biermann and Alexander Eng who were both selected as winners! @MCWSurgery @mcwsurgonc
Y. David Seo MD retweeted
New in @Cancer_Cell from @MDAndersonNews colleagues @BullmanLab @CJohnstonLab1 on effects of tumor #microbiome on cancer cell cycle & chemoresistance
Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest
cell.com/cancer-cell/fulltex…































